Glycomimetics
71 employees on LinkedIn · 2 known investors
GlycoMimetics is a company developing cancer therapies, aiming to advance treatment options for people living with cancer. It operates in the oncology-focused biotech field.
Investors · 2
Frequently asked questions
- What does Glycomimetics do?
- GlycoMimetics is a company developing cancer therapies, aiming to advance treatment options for people living with cancer. It operates in the oncology-focused biotech field.
- Who are Glycomimetics's investors?
- Glycomimetics's investors include New Enterprise Associates (NEA), Sanofi Ventures.